ADx NeuroSciences

Foundation date

16/09/2011

Sector

#Biotechnology - Therapeutics

Subsector

We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.

Upcoming events

Latest news

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

  • Innovating today, creating tomorrow: the VIB Bio-Incubator

    Thursday April 18th 2024

  • BioLizard Appoints Matthew Hall as Director of Business Development

    Thursday April 18th 2024